Item 1. | |
(a) | Name of issuer:
enGene Holdings Inc. |
(b) | Address of issuer's principal executive
offices:
4868 rue Levy, Suite 220, Saint-Laurent, Quebec, Canada H4R 2P1 |
Item 2. | |
(a) | Name of person filing:
Fonds de solidarite des travailleurs et des travailleuses du Quebec |
(b) | Address or principal business office or, if
none, residence:
545, Cremazie Blvd. East, Suite 200
Montreal, Quebec, CANADA
H2M 2W4 |
(c) | Citizenship:
Quebec, Canada |
(d) | Title of class of securities:
Common Shares |
(e) | CUSIP No.:
29286M105 |
Item 3. | If this statement is filed pursuant to §§
240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
(a) | Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o); |
(b) | Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); |
(c) | Insurance
company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); |
(d) | Investment
company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); |
(e) | An
investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); |
(f) | An
employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); |
(g) | A
parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); |
(h) | A
savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.
1813); |
(i) | A
church plan that is excluded from the definition of an investment company under section 3(c)(14)
of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
(j) | A
non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S.
institution in accordance with § 240.13d-1(b)(1)(ii)(J), please
specify the type of institution: |
(k) | Group,
in accordance with Rule 240.13d-1(b)(1)(ii)(K). |
| |
Item 4. | Ownership |
(a) | Amount beneficially owned:
2,029,751 common shares (the sum of 1,583,179 common shares and 446,572 common shares issuable upon the exercise of 446,572 warrants). |
(b) | Percent of class:
4.5%, based on 44,662,149 common shares, the sum of (i) 44,215,577 common shares outstanding as of September 6, 2024, as reported in enGene Holdings Inc.'s Form 10-Q filed with the U.S. Securities and Exchange Commission on September 10, 2024 and (ii) 446,572 common shares that would result in the event that all of the 446,572 warrants held by the reporting person were exercised and no other outstanding warrants were exercised.
4.5 % |
(c) | Number of shares as to which the person has:
|
| (i) Sole power to vote or to direct the vote:
See row 5 of cover page.
|
| (ii) Shared power to vote or to direct the
vote:
See row 6 of cover page.
|
| (iii) Sole power to dispose or to direct the
disposition of:
See row 7 of cover page.
|
| (iv) Shared power to dispose or to direct the
disposition of:
See row 8 of cover page.
|
Item 5. | Ownership of 5 Percent or Less of a Class. |
| 
Ownership of 5 percent or less of a class |
Item 6. | Ownership of more than 5 Percent on Behalf of
Another Person. |
|
Not Applicable
|
Item 7. | Identification and Classification of the
Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or
Control Person. |
|
Not Applicable
|
Item 8. | Identification and Classification of Members
of the Group. |
|
Not Applicable
|
Item 9. | Notice of Dissolution of Group. |
|
Not Applicable
|